Ja. Connolly et al., PROSTATE-SPECIFIC ANTIGEN AFTER CRYOSURGICAL ABLATION OF THE PROSTATE- DEFINING THE APPROPRIATE RESPONSE, Urologic clinics of North America, 24(2), 1997, pp. 415
The ability of prostate-specific antigen (PSA) to predict long-term cu
re after cryotherapy for localized prostate cancer is not known becaus
e experience with this treatment modality is limited; however, it appe
ars that a PSA value of 0.5 ng/mL or less at 6 months or longer after
cryotherapy is associated with a high probability of a negative post-t
reatment biopsy (greater than 95%). An undetectable PSA (less than 0.1
ng/mL) 3 months after the procedure is associated with a likelihood o
f a negative biopsy at 6 months and low, stable PSA levels up to 2 yea
rs.